About Us

Who are we?

The Artificial Vision Research Consortium is an international task-force of scientists and clinicians from the fields of ophthalmology, biomedical engineering and vision restoration who are working on a range of vision restoration technologies, including stem cells, gene therapy, visual prostheses and optogenetics.

Aim of the consortium

The overall aim is to promote a more cohesive approach to psychophysical testing of patients with severe blindness to facilitate comparison of outcomes among groups with different devices and biological and stimulation strategies. For a summary of the aspirations of this consortium, you can read the initial publication by Rizzo and Ayton.

Chairs and founding members

  • Joseph F. Rizzo III, M.D., David G. Cogan Professor of Ophthalmology in the field of Neuro-ophthalmology, and Director of the Neuro-ophthalmology Service, Harvard Medical School & Co-Founder of the Boston Retinal Implant Project, Boston USA
  • Lauren N. Ayton , OD, Ph.D., Research Fellow, Centre for Eye Research Australia, Department of Ophthalmology, University of Melbourne & Clinical Program Leader of the Bionic Vision Australia Project, Melbourne Australia
  • Philip Hessburg, M.D., Medical Director, Detroit Institute of Ophthalmology, Henry Ford Health System, Detroit USA

Administrative and technical support

International Task Force – working group leaders

  • Prof Ian Bailey
  • Prof Duane Geruschat
  • Prof Gislin Dagnelie
  • Prof Robert Shepherd and Dr Matthew Petoe, Bionics Institute, Melbourne Australia
  • Prof Gary Rubin
  • Prof Philip Troyk

International Task Force – working group team members

International Task Force – at large members


  • Dr Rizzo is affiliated with the Boston Retinal Implant Project and has equity positions in Bionic Eye Technology and Visus Technology, and he holds a number of patents related to restoration of visual function for the blind.
  • Dr Ayton is affiliated with Bionic Vision Australia, and has no financial disclosures.
  • Dr Hessburg is not affiliated with any vision restoration technology or group.
  • Detroit Institute of the Ophthalmology and the Henry Ford Health System have no affiliations or disclosures to report.

Please note that the information provided on this website is intended as a guide only, and should not replace treatment and advice from your medical or eye care practitioner. If you have any questions regarding your eye condition or potential interventions, please speak to your health care practitioner.

Contact artificial vision research

Learn more about our program

Schedule Appointment Online

If this is an emergency, call 911 or go to your nearest emergency department.

For your safety, please select a MyChart video visit on demand or call our MyCare Advice Line at 844-262-1949 before scheduling if:

  • You currently have a temperature greater than 100.4 degrees Fahrenheit
  • In the past 21 days, you have been diagnosed with COVID-19
  • In the past 14 days, you have had contact with anyone diagnosed with COVID-19
  • You are experiencing a new loss of taste and/or sense of smell
  • If you have experienced two or more of the following symptoms in the last 3 days:
    • fever
    • chills
    • drenching sweats
    • new cough
    • shortness of breath
    • body aches
    • headache
    • sore throat
    • runny nose or nasal congestion
    • nausea/vomiting/diarrhea

Henry Ford Health System is committed to ensuring our Deaf or hard-of-hearing patients and visitors have equal access to all services. We provide the appropriate auxiliary aids and services, including qualified sign language interpreters, TTYs and other assistive listening devices, at no cost. To request assistance, call 313-916-1896 or email CommunicationAccess@hfhs.org.

Schedule Appointment for